CELL EVALUATION & THERAPY
CELL EVALUATION & THERAPY
批准号:
9248291
负责人:
GUSTAVO WALTER LEONE
金额:
$9.06万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2019-03-31
关键词:
Alpha CellApoptosisBiological AssayBiological Response Modifier TherapyCancer CenterCancer Center Support GrantCell CycleCell ProliferationCell SeparationCell TherapyCell surfaceCellsClinicalClinical ResearchConsultationsCyclic GMPDataData AnalysesDetectionDevelopmentDoctor of PhilosophyEquipmentExperimental DesignsFlow CytometryFundingGoalsHealthcareHumanImmune responseImmunologic MonitoringImmunophenotypingInstructionLasersMalignant NeoplasmsMeasurementMedicalMembraneMethodologyMethodsMissionPatientsPeer ReviewPhasePopulationPreparationProteinsPublicationsRegulationResearchResearch PersonnelResearch Project GrantsResource SharingSamplingServicesSideSouth CarolinaSpeedStaining methodStainsTechnologyTherapy EvaluationTissuesTrainingTranslational ResearchUniversitiesbasecell preparationcost effectiveexperimental studygene therapyinnovationlaboratory experimentmanufacturing facilitymembernovelpre-clinicalsuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Hollings Cancer Center (HCC) Cell Evaluation & Therapy (CET) Shared Resource offers HCC
investigators comprehensive analytic flow cytometry and high-speed cell sorting services and the capacity to
generate human cellular and tissue-based products for use in translational research. The mission of the
CET Shared Resource is to provide an integrated platform where HCC users can evaluate pre-clinical or
clinical experimental data in a cell-specific manner and use the cell-manufacturing facility to bring the cellular
product to patients. Directed by Kevin F. Staveley-O'Carroll, MD, PhD, with two Associate Directors,
Amanda C. LaRue, PhD and Shikhar Mehrotra, PhD, this facility provides extensive expertise, an active
educational platform, and development of new methodologies within the facility.
The specific objectives of the HCC CET Shared Resource are to provide:
• Multi-parametric and multi-laser measurements including apoptosis, cell proliferation, cell cycle
distribution, and immunophenotyping, as well as detection of intracellular proteins, membrane
perturbations, and bioactive molecules.
• Expanded cell therapy and gene therapy-based bio-therapeutic products for Phase I and II clinical
studies employing current cGMP as required by federal regulations.
• Immune monitoring services to evaluate the immune response in patients and provide data for basic
laboratory experiments.
• Regulatory expertise in the preparation of cell and possibly gene therapy based INDs.
• High-speed cell sorting based on cell surface marker immunostaining and/or side-population staining.
• Consultation and assistance concerning experimental design, sample preparation, and data analysis.
• Training in the use of routine flow cytometric technology and analytical equipment.
• Advanced training in novel flow cytometric assays that are new and/or specific to HCC researchers'
applications.
• New methods to assist HCC members in performing cutting-edge research.
CET-supported experiments during the current CCSG project period have led to the success of more than 18
NCI-funded research project grants and more than 100 peer-reviewed publications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leaders of Scientific Research Programs
-
批准号:9248281
-
项目类别:
-
资助金额:$17.22万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
Administration
-
批准号:9248296
-
项目类别:
-
资助金额:$18.07万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
LIPIDOMICS SHARED RESOURCE GROUP
-
批准号:9248286
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
Clinical Trials Office and Data & Safety Monitoring
-
批准号:9248289
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
BIOREPOSITORY & TISSUE ANALYSIS
-
批准号:9248298
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
CANCER CONTROL
-
批准号:9248285
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
Planning and Evaluation
-
批准号:9248294
-
项目类别:
-
资助金额:$3.47万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
Senior Leadership
-
批准号:9248293
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
DEVELOPMENTAL CANCER THERAPEUTICS
-
批准号:9248284
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2017
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
Leaders of Scientific Research Programs
-
批准号:9454303
-
项目类别:
-
资助金额:$16.81万
-
财政年份:--
-
负责人:GUSTAVO WALTER LEONE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: